ArticleMikrochimica acta2026
A newly developed chiral Ru-phe probe for highly sensitive enantioselective detection of tryptophan.
Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
A chiral ruthenium probe (Ru-phe) for determination of amino acids was constructed by conjugating L-phenylalanine to a Ru-MOF precursor via EDC/NHS activation. The stereogenic center and aromatic side chain of L-Phe establish a chiral microenvironment that facilitates π–π stacking and hydrophobic interactions with tryptophan, thereby enabling efficient enantioselective recognition. The Ru-phe electrochemiluminescence (ECL) sensing platform achieved broad linear quantification ranges—0.1 nM – 1 mM for L-Trp and 10 nM – 1 mM for D-Trp. The detection limits were 0.06 nM for L-Trp and 13 nM for D-Trp. Moreover, the method showed strong reproducibility in human serum samples, with relative standard deviations (RSDs) of 0.9–1.8% for L-Trp. Machine-learning-assisted classification further improved enantiomer discrimination accuracy to 96%. Overall, this work introduces an efficient and highly sensitive ECL approach that enables practical enantiomeric determination of tryptophan, offering strong potential for clinical monitoring.
Indexed as
Identifiers
41882413What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.